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A series of 16 oxadiazole and triazolothiadiazole derivatives were designed, synthesized and 
evaluated as mushroom tyrosinase inhibitors. Five derivatives were found to display high 
inhibition on the tyrosinase activity ranging from 0.87 to 1.49 lM. Compound 5 exhibited 
highest tyrosinase inhibitory activity with an IC50 value of 0.87 ± 0.16 lM. The in silico 
protein–ligand docking using AUTODOCK 4.1 was successfully performed on compound 5 
with significant binding energy value of 5.58 kcal/mol. The docking results also showed that 
the tyrosinase inhibition might be due to the metal chelating effect by the presence of thione 
functionality in compounds 1–5. Further studies revealed that the presence of hydrophobic 
group such as cycloamine derivatives played a major role in the inhibition. Piperazine moiety 
in compound 5 appeared to be involved in an extensive hydrophobic contact and a 2.9 Å 
hydrogen bonding with residue Glu 182 in the active site. 
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